Workflow
Chongqing Baiya Sanitary Products (003006)
icon
Search documents
百亚股份(003006) - 年度股东大会通知
2025-03-21 12:45
证券代码:003006 证券简称:百亚股份 公告编号:2025-014 重庆百亚卫生用品股份有限公司 关于召开2024年年度股东大会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误 导性陈述或重大遗漏。 重庆百亚卫生用品股份有限公司(以下简称"公司")于2025年3月21日召 开的第四届董事会第四次会议审议通过了《关于召开2024年年度股东大会的议 案》,同意公司于2025年4月11日下午15:00召开公司2024年年度股东大会(以下 简称"本次股东大会"),现将具体事项公告如下: 一、召开会议的基本情况 1、股东大会届次:2024年年度股东大会 2、股东大会召集人:公司董事会 3、会议召开的合法、合规性:公司第四届董事会第四次会议审议通过《关 于召开2024年年度股东大会的议案》,本次股东大会的召开符合有关法律、行政 法规、部门规章、规范性文件、《上市公司股东大会规则》和《公司章程》的相 关规定。 4、会议召开的时间 (1)现场会议召开时间:2025年4月11日(星期五)15:00 (2)网络投票时间:2025年4月11日(星期五) 其中,通过深圳证券交易所交易系统进行网络 ...
百亚股份(003006) - 监事会关于2021年股票期权与限制性股票激励计划相关事项的核查意见
2025-03-21 12:45
关于 2021 年股票期权与限制性股票激励计划 相关事项的核查意见 重庆百亚卫生用品股份有限公司(以下简称"公司")监事会根据《中华人 民共和国公司法》《上市公司股权激励管理办法》等法律、法规及《公司章程》 的规定,对公司 2021 年股票期权与限制性股票激励计划(以下简称"激励计划") 相关事项进行了核查并发表意见如下: 1、关于 2021 年股票期权与限制性股票激励计划第三个解除限售期解除限 售条件成就的核查意见 根据《上市公司股权激励管理办法》《2021 年股票期权与限制性股票激励计 划(草案)(修订稿)》(以下简称"《激励计划(草案)(修订稿)》")的有关规定, 公司激励计划第三个解除限售期解除限售条件已成就,本次符合解除限售条件的 激励对象共 61 名,可解除限售的限制性股票数量共 639,000 股,占公司目前总 股本的 0.1488%。监事会对本次符合解除限售条件的激励对象名单进行了核查, 认为公司本次解除限售的激励对象符合《激励计划(草案)(修订稿)》、相关法 律法规和规范性文件规定的条件,其作为公司限制性股票激励对象的主体资格合 法、有效。公司对上述事项的审议程序合法合规,不存在损害公司或股 ...
百亚股份(003006) - 监事会决议公告
2025-03-21 12:45
证券代码:003006 证券简称:百亚股份 公告编号:2025-004 第四届监事会第四次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误 导性陈述或重大遗漏。 一、监事会会议召开情况 重庆百亚卫生用品股份有限公司(以下简称"公司")第四届监事会第四次 会议于 2025 年 3 月 21 日在公司会议室以现场会议方式召开。会议通知于 2025 年 3 月 10 日以电话和邮件等电子方式发出。会议应到监事 3 人,实到监事 3 人。 会议由监事会主席陈治芳女士召集并主持,公司董事会秘书及证券事务代表列席 了会议。本次会议的召集及召开程序符合《公司法》和《公司章程》等法律法规、 规章制度的有关规定。 二、监事会会议审议情况 经全体监事充分讨论和认真审议,作出如下决议: 1、审议通过了《关于<2024 年度监事会工作报告>的议案》 2024 年度,公司监事会严格按照《公司法》《证券法》《公司章程》及《监事 会议事规则》等有关规定和要求,恪尽职守、勤勉尽责地履行监督职责,依法独 立行使职权。监事会成员通过列席公司董事会、出席股东大会的形式,对会议召 开程序、公司经营活动、财务状 ...
百亚股份(003006) - 董事会决议公告
2025-03-21 12:45
一、董事会会议召开情况 证券代码:003006 证券简称:百亚股份 公告编号:2025-003 重庆百亚卫生用品股份有限公司 第四届董事会第四次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导 性陈述或重大遗漏。 《2024 年度董事会工作报告》具体内容详见公司同日在巨潮资讯网 (www.cninfo.com.cn)披露的《2024 年年度报告》相关章节内容。 公司现任独立董事江积海先生、郝颖先生、马赟先生,离任独立董事侯茜女 士、晏国菀女士提交了《2024 年度独立董事述职报告》,并将在公司 2024 年年度 股东大会上述职。此外,公司现任独立董事向公司董事会提交了《独立董事关于 独立性自查情况的报告》,公司董事会对现任独立董事独立性情况进行评估并出 具了《董事会关于独立董事独立性自查情况的专项报告》。具体内容详见公司同 日在巨潮资讯网披露的《2024 年度独立董事述职报告》《董事会关于独立董事独 立性自查情况的专项报告》。 本议案尚需提交公司股东大会审议。 重庆百亚卫生用品股份有限公司(以下简称"公司")第四届董事会第四次 会议于 2025 年 3 月 21 日在 ...
百亚股份(003006) - 2024 Q4 - 年度财报
2025-03-21 12:45
Financial Performance - The company's operating revenue for 2024 reached ¥3,254,235,621, representing a 51.77% increase compared to ¥2,144,145,687 in 2023[25]. - Net profit attributable to shareholders for 2024 was ¥287,671,463, up 20.74% from ¥238,251,847 in 2023[25]. - The basic earnings per share for 2024 increased to ¥0.67, a 19.64% rise from ¥0.56 in 2023[25]. - The total assets at the end of 2024 amounted to ¥2,150,862,064, reflecting a 14.14% growth from ¥1,884,474,560 at the end of 2023[25]. - The company reported a net cash flow from operating activities of ¥325,216,399 in 2024, a slight decrease of 1.86% from ¥331,394,248 in 2023[25]. - The company's weighted average return on equity for 2024 was 20.83%, up from 18.17% in 2023[25]. - The gross profit margin for the company improved to 53.2%, with Free Point's gross profit margin at 55.8%, both showing increases from the previous year[53]. - The company reported a significant increase in revenue, achieving a total of 1.2 billion CNY for the fiscal year, representing a 15% year-over-year growth[127]. Market and Product Development - The market size of absorbent hygiene products in China reached ¥1160.4 billion in 2023, growing by 4.1% compared to 2022[33]. - The women's hygiene products market size was ¥703.4 billion in 2023, an increase of 8.2% from 2022[33]. - The adult incontinence products market size grew by 11.1% to ¥134.4 billion in 2023[33]. - The company plans to enhance product innovation and expand its market presence in response to changing consumer demands and emerging retail channels[34]. - The company has launched new product lines, including probiotic series sanitary napkins and ultra-thin baby diapers, catering to diverse consumer needs[41][43]. - The company is conducting research on several new products, including upgraded probiotics and smart health monitoring sanitary products[70]. - New product development includes the launch of a biodegradable product line, expected to contribute an additional 200 million CNY in revenue[127]. Marketing and Sales Strategy - The company has adopted a diversified sales strategy, utilizing distributors, key accounts, and e-commerce platforms to expand market reach[46]. - The company has established a strong presence in e-commerce, leveraging platforms like Douyin, Tmall, and JD.com to enhance its market coverage[47]. - The company continues to enhance its marketing strategy, emphasizing e-commerce and new channels to boost brand awareness and consumer reach[54]. - The company plans to increase its marketing budget by 40% to enhance brand visibility and customer engagement[127]. - The company is focusing on expanding its market presence in key provinces such as Guangdong, Hunan, Hubei, Hebei, and Jiangsu, with a revenue increase of 82.1% in peripheral provinces[54]. Corporate Governance and Compliance - The company has established a governance structure that complies with relevant laws and regulations, ensuring the protection of shareholder rights[111]. - The board of directors held 6 meetings during the reporting period, adhering to legal and regulatory requirements[112]. - The company emphasizes transparency in information disclosure, adhering to legal requirements and ensuring timely and accurate communication with shareholders[113]. - The company has a dedicated financial department with an independent accounting system and bank accounts, ensuring financial independence from the controlling shareholder[117]. - The company has confirmed that all raised funds have been used according to the committed purposes without any major changes in project feasibility[90]. Research and Development - The company invested ¥72 million in research and development in 2024, resulting in the addition of 15 new patents[56]. - The company has a strong emphasis on R&D, with a dedicated team that has been recognized as a "National Intellectual Property Advantage Enterprise" and has received various industry certifications[39]. - The company has implemented a comprehensive production model, covering product R&D, raw material procurement, production, and sales, ensuring effective control over the entire supply chain[44]. Social Responsibility and Community Engagement - The company has committed to donating CNY 1 million worth of sanitary napkin products annually to support poverty alleviation efforts in Chongqing over the next ten years[164]. - In 2024, the company conducted over a hundred public lectures on physiological and psychological health for over 10,000 adolescent girls, promoting awareness and education on health and self-protection[166]. - The company plans to continue its poverty alleviation strategy in 2025, focusing on donations and the dissemination of menstrual health knowledge through hundreds of campus activities[167]. Financial Management and Investment - The company has maintained a stable profit distribution policy, with a total cash dividend of 623 million yuan distributed since its listing, accounting for 74.49% of net profit[107]. - For 2024, the company plans to distribute a cash dividend of 2.36 billion yuan, which is 5.5 yuan per 10 shares, representing 82% of net profit[107]. - The company has established a compensation mechanism linked to the performance of its return measures, which will be adhered to by all directors and senior management[181]. - The company has committed to ensuring the accuracy and completeness of its prospectus and will bear legal responsibilities for any misstatements or omissions[179]. Employee Management - The total number of employees at the end of the reporting period is 2,348, with 2,065 from the parent company and 283 from major subsidiaries[141]. - The employee composition includes 639 production personnel, 1,464 sales personnel, 84 technical personnel, 52 financial personnel, and 109 administrative personnel[141]. - The company has implemented a dynamic salary management system that combines rewards and penalties, ensuring optimized and efficient salary management[143]. Environmental Initiatives - The company has actively responded to national low-carbon and environmental protection initiatives, emphasizing the importance of reducing comprehensive energy consumption[162]. - The implementation of the photovoltaic projects is projected to reduce standard coal consumption by approximately 215 tons and decrease carbon dioxide emissions by about 918 tons[162]. - The company invested CNY 585,000 to establish a heat recovery system for air compressors, which is expected to save approximately 30,000 cubic meters of gas and reduce gas expenses by CNY 108,000 from July to December 2024[163].
百亚股份(003006) - 关于2024年度利润分配预案的公告
2025-03-21 12:45
证券代码:003006 证券简称:百亚股份 公告编号:2025-016 重庆百亚卫生用品股份有限公司 关于 2024 年度利润分配预案的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导 性陈述或重大遗漏。 重庆百亚卫生用品股份有限公司(以下简称"公司")于 2025 年 3 月 21 日 召开的第四届董事会第四次会议和第四届监事会第四次会议分别审议通过了《关 于 2024 年度利润分配预案的议案》,该议案尚需提交公司股东大会审议,现将相 关情况公告如下: 一、审议程序 1、董事会审议情况 2025 年 3 月 21 日,公司第四届董事会第四次会议审议通过了《关于 2024 年度利润分配预案的议案》,同意将本次利润分配预案提交公司股东大会审议。 2、监事会审议情况及意见 2025 年 3 月 21 日,公司第四届监事会第四次会议审议通过了《关于 2024 年度利润分配预案的议案》。经审核,监事会认为:公司 2024 年度利润分配预案 充分考虑了公司经营状况及未来发展的资金需求等综合因素,与公司实际经营业 绩匹配,有利于维护公司全体股东的长期利益,保证公司的稳定经营和健康发展; ...
百亚股份(003006) - 关于对深圳证券交易所关注函回复的公告
2025-03-20 10:30
证券代码:003006 证券简称:百亚股份 公告编号:2025-002 回复说明: 经核查,公司对报道中所述违规业务并不知悉,且公司未曾参与此类违规业 务。公司与涉事违规公司不存在交易往来,亦不存在关联关系、合作关系。 问题二:你公司有关原材料采购、生产残次品处置的制度和实际执行情况, 内部控制机制是否有效运转,是否存在采购不合格原材料、残次品违规流通或者 处置的漏洞,如是,你公司拟采取的整改完善、消除影响措施。 回复说明: 关于对深圳证券交易所关注函回复的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误 导性陈述或重大遗漏。 重庆百亚卫生用品股份有限公司(以下简称"公司")于 2025 年 3 月 16 日 收到深圳证券交易所(以下简称"深交所")上市公司管理一部下发的《关于对 重庆百亚卫生用品股份有限公司的关注函》(公司部关注函(2025)第 2 号,以 下简称"关注函"),要求公司就所提问题进行核实并做出书面说明并对外披露, 同时抄送重庆证监局上市公司监管处。 公司收到关注函后高度重视,立即组织相关部门对涉及的相关问题逐项进行 认真核查与落实,现将有关情况回复如下: 问题 ...
百亚股份开盘跌停 稳健医疗大幅低开
人民财讯3月17日电,3月17日,百亚股份跌停开盘、稳健医疗低开超8%。 2025年"3·15"晚会曝光违规翻新卫生巾事件后,"自由点"卫生巾母公司百亚股份在3月16日早间收到深 交所下发的关注函。 同日,全棉时代母公司稳健医疗也收到了深交所下发的关注函,对上述问题同样进行了追问。 ...
百亚股份收到深交所关注函
请公司自查并说明:一、你公司是否知悉、参与报道所述违规业务,和涉事违规公司是否存在交易往来 或者应予说明的关联、合作关系。 二、你公司有关原材料采购、生产残次品处置的制度和实际执行情况,内部控制机制是否有效运转,是 否存在采购不合格原材料、残次品违规流通或者处置的漏洞,如是,你公司拟采取的整改完善、消除影 响措施。 人民财讯3月16日电,3月16日,百亚股份收到深交所关注函。 有媒体报道某纸制品有限公司(简称"涉事违规公司")收购品牌纸尿裤和卫生巾残次品,违规翻新后销 售,或者处理形成回收料回售,其中提及公司品牌产品。 ...
百亚股份:全渠道捷报频传,期待38表现-20250228
Tianfeng Securities· 2025-02-27 16:00
Investment Rating - The report maintains a "Buy" rating for the company [4][6][18] Core Views - The company has achieved top rankings on multiple e-commerce platforms, including Tmall and Pinduoduo, which sets a strong foundation for the upcoming March 8th sales campaign [1][2] - The management team and distributors are actively engaged in promoting the brand and utilizing innovative marketing strategies to enhance store performance during the March 8th festival [2][3] - The company is focusing on brand strength and customer acquisition through various marketing initiatives, including collaborations with brand ambassadors and unique promotional events [3][4] Financial Projections - The company expects to achieve a net profit of 290 million, 370 million, and 480 million yuan for the years 2024, 2025, and 2026 respectively, with corresponding P/E ratios of 35, 27, and 21 [4][5] - Revenue is projected to grow significantly from 1.61 billion yuan in 2022 to 5.30 billion yuan by 2026, reflecting a compound annual growth rate (CAGR) of approximately 24.61% [5][12] - The EBITDA is expected to increase from 318.54 million yuan in 2022 to 647.84 million yuan in 2026, indicating strong operational performance [5][12] Key Financial Metrics - The company's earnings per share (EPS) is projected to rise from 0.44 yuan in 2022 to 1.12 yuan in 2026 [5][12] - The gross margin is expected to improve from 45.11% in 2022 to 54.19% in 2026, showcasing enhanced profitability [13] - The asset-liability ratio is forecasted to increase from 26.05% in 2022 to 35.48% in 2026, indicating a stable financial structure [13]